We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Results Confirm Effectiveness of Echotherapy for Breast Fibroadenoma

By MedImaging International staff writers
Posted on 21 Jun 2016
Print article
Image: The Ecopulse medical device for the treatment of BFAs and benign thyroid nodules (Photo courtesy of Theraclion).
Image: The Ecopulse medical device for the treatment of BFAs and benign thyroid nodules (Photo courtesy of Theraclion).
A French therapeutic ultrasound company has announced the results of a German trial of its ecotherapy technology that have confirmed its effectiveness in the destruction of Breast FibroAdenoma nodules.

The results of the Breast FibroAdenoma (BFA) trial in which 27 patients were enrolled, were presented at the German Congress of Senology in Dresden, Germany, at the end of May 2016. The aim of the study was to evaluate the safety and efficacy of the new technique.

The trial took place at Tübingen University (Tübingen, Germany). The researchers used therapeutic ultrasound technology developed by Theraclion (Malakoff, France).

Biopsies were performed 12 months after the ecotherapy procedure and showed that nearly 24 of the 27 patients (nearly 90%) had no residual vital BFA tissue. All the patients except for one were prepared to recommend the procedure. The original aim of the non-invasive BFA treatment was to reduce the volume of BFAs, however the new trial confirmed that complete tissue destruction was also possible. The procedure does not using ionizing radiation, and could be used to treat breast cancer patients in the near future.

CMO of Theraclion, Michel Nuta, said, “These results are extremely encouraging. Echotherapy has initially been designed for volume reduction of a nodule, not for its complete destruction. These preliminary results show that there is reason to believe that by adapting the protocol, complete tissue destruction can be obtained.”

Related Links:
Tübingen University
Theraclion
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
DR Flat Panel Detector
1500L
New
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.